MED Medifast, Inc.
Consumer Cyclical$13.09+3.97%ClosedMarket Cap: $145.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.70
P/S
0.40
EV/EBITDA
46.36
DCF Value
$60.90
FCF Yield
-1.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.1%
Operating Margin
-4.1%
Net Margin
-5.8%
ROE
-9.7%
ROA
-7.9%
ROIC
-6.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $76.0M | 68.1% | $-1.1M | $-2.1M | $— | — |
| Q4 null | $75.1M | 69.4% | $-7.8M | $-18.1M | $— | — |
| FY null | $385.8M | 71.3% | $-14.2M | $-18.7M | $— | — |
| Q3 null | $89.4M | 69.5% | $-4.1M | $-2.3M | $— | — |
| Q2 null | $105.6M | 72.6% | $-1.1M | $2.5M | $— | — |
| Q1 null | $115.7M | 72.8% | $-1.3M | $-772.0K | $— | — |
| Q4 null | $119.0M | 74.1% | $709.0K | $801.0K | $— | — |
| FY null | $602.5M | 73.8% | $2.9M | $2.1M | $— | — |
| Q3 null | $140.2M | 75.4% | $2.1M | $1.1M | $— | — |
| Q2 null | $168.6M | 73.2% | $-7.9M | $-8.2M | $— | — |
| Q1 null | $174.7M | 72.8% | $7.9M | $8.3M | $— | — |
| Q4 2023 | $191.0M | 74.0% | $8.7M | $6.0M | $0.50 | — |